Clinical Practice
Selegiline Patch for TRD: A PMHNP Prescribing Protocol
The selegiline patch (EMSAM) is the MAOI with no diet rules at 6 mg. A PMHNP protocol for candidates, washouts, dosing, tyramine, and monitoring in TRD.
Tagged
Treatment-Resistant Depression
Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
More Articles
Industry
Psychedelic Therapy in 2026: What PMHNPs Must Know
No psychedelic is FDA-approved yet, but two FDA notices in July 2026 moved the timeline. What PMHNPs need to know about psilocybin, MDMA, and state programs.
Clinical Practice
Pramipexole for Treatment-Resistant Depression: What PMHNPs Should Know
The PAX-D trial showed pramipexole reduced treatment-resistant depression symptoms by week 12. Here's what PMHNPs need to know about dosing, monitoring, and clinical use.
Clinical Practice
ProlivRx for Depression: At-Home Neuromodulation PMHNPs Should Know
ProlivRx is the first FDA-approved at-home neuromodulation for treatment-resistant depression. Here's what PMHNPs need to know about prescribing it.
Clinical Practice
Ketamine and Esketamine in Psychiatric Practice: What PMHNPs Need to Know in 2026
Ketamine and esketamine are reshaping treatment-resistant depression care, with expanded indications and new delivery models emerging in 2026.